Hologic/Cytyc Merger Combines Diverse Women’s Health Device Portfolios
This article was originally published in The Gray Sheet
Executive Summary
The combination of mammography device maker Hologic and cervical cancer test firm Cytyc will create a women's health powerhouse with $1.44 billion in combined annual revenues